Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Immunotech Biopharm Ltd ( (HK:6978) ).
Immunotech Biopharm Ltd has announced a change in its board of directors, with Ms. Yu Xiaohui appointed as a non-executive director and a member of the audit committee, replacing Mr. Tao Ran who resigned due to other job arrangements. This leadership change reflects the company’s ongoing strategic adjustments and may influence its future direction in the pharmaceutical sector.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a company incorporated in the Cayman Islands, focusing on the pharmaceutical industry. It is involved in research and development, with a market focus on biopharmaceutical innovations.
YTD Price Performance: 76.96%
Average Trading Volume: 839,448
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.09B
For an in-depth examination of 6978 stock, go to TipRanks’ Stock Analysis page.